Breakout Labs
VC Fund
San Francisco, United States
Breakout Labs is a bold re-envisioning of the way innovative science and technology is funded. We invite early-stage companies from around the world to apply for funding of specific milestones on a path to achieving radical advances and far-reaching impact. Our unique revolving fund model allows successful companies to help fund the next generationof innovation.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Breakout Labs invests in
Stages Breakout Labs invests in
Countries Breakout Labs invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hemai Parthasarathy
|
|||
Julia Moore
|
|||
Investment Focus
Industry
- Biotechnology 4 (57%)
- Agriculture 3 (43%)
- Therapeutics 2 (29%)
- AgTech 1 (14%)
- Aerospace 1 (14%)
Stage
- Grant 3 (43%)
- Seed 2 (29%)
- Series A 1 (14%)
- Private Equity 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hemai Parthasarathy
Scientific Director
|
Scientific Director | Total investments: 1 | Find email | |
Jim O'Neill
Co-Founder
|
Co-Founder | Total investments: 1 | Find email | |
|
Julia Moore
Portfolio Director
|
Portfolio Director | Total investments: 3 | Find email | |
Lindy Fishburne
Founder & Executive Director
|
Founder & Executive Director | Total investments: 7 | Find email | |
Peter Thiel
Founder & CEO
|
Founder & CEO | Total investments: 234 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Carolina Seed Systems
|
Carolina Seed Systems employs cutting-edge genetic technologies to produce market-ready hybrid grain. | $50K / Grant / Apr 04, 2023 | |
Napigen
|
We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration. | $7.9M / Seed / Jul 12, 2022 | |
Positron Dynamics
|
Positron Dynamics LLC was founded in 2011 by Ryan Weed and Joshua Machacek. Our area of expertise is in the use of ‘cold’ positrons as a diagnostic for materials and in low-energy collisions with atoms and molecules. The company develops positron beam technologies for use in non-destructive testing (NDT) of critical components in the aerospace anddefense markets. At the heart of these technologies is a novel method of producing and moderating positrons, for which several patents were awarded in 2011. | $1.5M / Private Equity / Jan 09, 2017 | |
Modern Meadow
|
Modern Meadow is developing fundamentally new approaches to growing animal products. This includes cultured leather and meat products that require no animal slaughter and much lower inputs of land, water, energy, and chemicals. | $11M / Series A / May 31, 2014 | |
Siva Therapeutics
|
Siva Therapeutics Inc., a biotechnology company, engages in the development of nanotechnology approaches for the treatment of cancer. It develops SivaRods, a photo thermal device, which uses heat to irreversibly damage solid tumor tissues. The company was founded in 2011 and is based in Boulder, Colorado. | $400K / Seed / Dec 20, 2013 | |
|
Siva Therapeutics
|
Siva Therapeutics Inc., a biotechnology company, engages in the development of nanotechnology approaches for the treatment of cancer. It develops SivaRods, a photo thermal device, which uses heat to irreversibly damage solid tumor tissues. The company was founded in 2011 and is based in Boulder, Colorado. | $350K / Grant / Sep 26, 2012 | |
Longevity Biotech
|
Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Founded in 2010 by President Mr. Scott Shandler, Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymesand tunable to very stable molecular structures. | $350K / Grant / Apr 26, 2012 |
Co-Investors
The Thiel Foundation
2 deals together
Alchemist Accelerator
1 deal together
Artis Ventures
1 deal together
Black Point Group
1 deal together
Boston Harbor Angels
1 deal together
Collaborative Fund
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Breakout Labs invest in?
Breakout Labs invests primarily in Biotechnology, Agriculture and Therapeutics startups, most often at Grant and Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Breakout Labs?
Public channels for Breakout Labs include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Breakout Labs?
The team at Breakout Labs includes Hemai Parthasarathy (Scientific Director), Jim O'Neill (Co-Founder) and Julia Moore (Portfolio Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
